Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin prophylaxis to reduce post-cesarean section infection
IRCT20130812014333N160Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of azithromycin in surgical site infection (SSI), sponsored by Kermanshah University of Medical Sciences. Primary endpoint: post-operative infection rate. Started Jan 2021; status: completed.
02
Drugs
azithromycin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on IRCT20130812014333N160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130812014333N160.